An interventional study of CCT+MBLT and CCT+ION in Mild Traumatic Brain Injury and Posttraumatic Stress Disorder, sponsored by VA Office of Research and Development. Recruiting at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 27 studies in Brain Concussion by VA Office of Research and Development — 8 open to participants now, 8 under way, 1 of them phase 3. Brain Concussion · VA Office of Research and Development.
Among the 27 studies in Brain Concussion by VA Office of Research and Development, this one is the 5th largest by planned enrollment of the 25 interventional ones that give a count, is the only one that started in 2026, is one of 18 with no phase, and was the 26th registered.
641 studies on the registry are indexed under Brain Concussion; 167 are open to participants now.
Browse Brain Concussion studies →8 of the 27 studies in Brain Concussion by VA Office of Research and Development are open now, in 1 country. Recruiting first, the newest first:
VA Office of Research and Development · Sites in United States
Ages 21–55
VA Office of Research and Development · Sites in United States
Ages 22–65
VA Office of Research and Development · Sites in United States
Ages 18–65
VA Office of Research and Development · Sites in United States
Ages 18+
VA Office of Research and Development · Sites in United States
Ages 30–90 · Healthy volunteers
By country, each count listing its studies:
Of the 114 Brain Concussion studies recruiting now, 34 (30%) set no upper age limit and 73 (64%) stop at 75 or younger; 24 take children under 18; 38 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
27 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 3 · Phase 3 1
First in 2008; this study’s year is marked. 1 started in 2026.
This study's planned enrollment of 144 is above the median of 63 across 449 interventional studies indexed under Brain Concussion.
Median enrollment 66 across the 25 interventional studies, 446 across the 2 observational. Of the 19 that completed or were terminated, 17 (89%) have results posted.
This tab as a report to print or save as PDF → With an account.
VA Office of Research and Development is the lead sponsor of 1,774 studies on the registry; 394 are open to participants now.
Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.
5 of the studies in Brain Concussion by VA Office of Research and Development that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04867317Phase 3VA Office of Research and DevelopmentGrowth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD) | 2027-02-28 |
| NCT06109909VA Office of Research and DevelopmentPilot Study of Neurofeedback for Photosensitivity in Mild Traumatic Brain Injury | 2026-11-30 |
| NCT04124029VA Office of Research and DevelopmentContributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD) | 2026-12-31 |
| NCT04043442VA Office of Research and DevelopmentrTMS Target Identification for Functional Disability in AUD+mTBI | 2027-03-31 |
| NCT05837676VA Office of Research and DevelopmentProblem-Solving Training for Concussion | 2027-03-31 |
Add all 5 to your calendar (.ics) → With an account.
Among the 27 studies in Brain Concussion by VA Office of Research and Development, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Posttraumatic stress disorder (PTSD) and mild TBI (mTBI) frequently co-occur in post-9/11 Veterans, and together are associated with worse cognitive performance, mental health, everyday functioning, community integration, quality of life, and treatment response than either condition alone. Additional comorbidities, such as depression and sleep disturbance, are common and further exacerbate these problems. The investigators will investigate Compensatory Cognitive Training (CCT) and Morning Bright Light Therapy (MBLT) vs Negative Ion Generator (ION), to directly target cognition, depression, and sleep disturbance and to improve CCT-associated rehabilitation outcomes. The investigator's randomized controlled trial in 144 Veterans with mTBI+PTSD across two VA sites will compare cognition, functioning, and other secondary outcomes following CCT+MBLT vs. CCT+ION. This study addresses the significant gap in services and evidence-based treatments for Veterans with mTBI+PTSD.
The investigators aim to compare CCT+MBLT with CCT+ION for improving cognition, functioning, and secondary outcomes in Veterans with mTBI+PTSD.
Objective cognitive performance and everyday functioning are co-primary outcomes. Depression and sleep disturbance are target mechanisms and secondary outcomes include PTSD symptom severity, post-concussive symptom severity, cognitive symptom severity, and quality of life.
Improvements in mood and sleep will be investigated as mediators. To explore for whom these interventions are most effective, the investigators will evaluate whether individual difference variables (e.g., demographics, premorbid functioning, treatment adherence) or baseline performance on primary and secondary outcome measures moderate intervention-related improvements in objective cognitive performance and everyday functioning.
The investigators will enroll a representative sample of 144 post-9/11 Veterans with mTBI+PTSD at two VA sites (San Diego and Portland). Assessments will be conducted at baseline, mid-treatment (5 weeks), post-treatment (10 weeks), and three-month follow-up.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Compensatory Cognitive Training + Morning Bright Light Therapy
Device: CCT+MBLT
Compensatory Cognitive Training + Negative Ion Generator
Device: CCT+ION
Compensatory Cognitive Training + Morning Bright Light Therapy (Aurora LightPad)
Also known as: Morning Bright Light Therapy Aurora LightPad lightbox
Compensatory Cognitive Training + Negative Ion Generator (SphereOne)
Also known as: SphereOne negative ion generator
Objective Cognitive Performance
Composite z score of Hopkins Verbal Learning Test-Revised; Wechsler Adult Intelligence Scale, Fourth Edition (WAIS-IV) Digit Span; WAIS-IV Coding; Delis-Kaplan Executive Function System (D-KEFS) Trails; D-KEFS Color-Word Interference; and the UCSD Performance-Based Skills Assessment-Brief (UPSA-B). There is no minimum or maximum value of a z score. Higher scores will reflect better outcomes.
Time frame: baseline, 10 weeks
Functioning
Composite z score of Brief Inventory of Psychosocial Functioning and the World Health Organization Disability Assessment Schedule 2.0. There is no minimum or maximum value of a z score. Higher scores will reflect better outcomes.
Time frame: baseline, 10 weeks
Insomnia Severity Index
Insomnia severity. Scores range from 0-28, with higher scores representing worse insomnia.
Time frame: baseline, 10 weeks
Pittsburgh Sleep Quality Index
Sleep quality. Scores range from 0-21, with higher scores representing worse sleep quality.
Time frame: baseline, 10 weeks
Total Sleep Time
Total Sleep Time derived from Actiwatch2. Minutes range from 0 to 1440 per day, with higher numbers reflecting more minutes of sleep.
Time frame: baseline, 10 weeks
Patient Health Questionnaire-9
Depression symptom severity. Scores range from 0-27, with higher scores reflecting worse depression symptoms.
Time frame: baseline, 10 weeks
PTSD Checklist for DSM-5
PTSD symptom severity. Scores range from 0-80, with higher scores reflecting worse PTSD symptoms.
Time frame: baseline, 10 weeks
Neurobehavioral Symptom Inventory
Postconcussive symptom severity. Scores range from 0-88, with higher scores reflecting worse neurobehavioral symptoms.
Time frame: baseline, 10 weeks
Subjective cognitive functioning
Mean score across Neuro-QOL Applied Cognition Executive Function and Neuro-QOL Applied Cognition General Concerns scales. The mean score has a range of 8-40, with higher scores reflecting better subjective cognitive functioning.
Time frame: baseline, 10 weeks
World Health Organization Quality of Life
Quality of life. Scores range from 0-100, with higher scores reflecting better quality of life.
Time frame: baseline, 10 weeks
Plan to share: No
No publications or documents are linked to this record.
Started Apr 2026 (actual). Primary completion is estimated for Sep 2030, 53 months after the start.
Of 249 non-industry interventional studies with no phase under Brain Concussion, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 47. This study's planned 53 months is above that.
Counting every sponsor, half of 265 studies reached it within 28 months; a quarter within 19 and three quarters within 47.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
VA Office of Research and Development →